3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Status
Recruiting
2
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Gastrointestinal
2
Conditions
Nasopharyngeal Carcinoma
20
Carcinoma, Non-Small-Cell Lung
18
Esophageal Squamous Cell Carcinoma
15
Breast Neoplasms
14
Triple Negative Breast Neoplasms
13
Squamous Cell Carcinoma of Head and Neck
11
Carcinoma, Hepatocellular
11
Stomach Neoplasms
8
Small Cell Lung Carcinoma
8
Uterine Cervical Neoplasms
6
Recurrence
6
Head and Neck Neoplasms
6
Colorectal Neoplasms
6
Carcinoma, Transitional Cell
5
Carcinoma, Renal Cell
5
Urinary Bladder Neoplasms
4
Sarcoma
4
Rectal Neoplasms
4
Neoplasm Metastasis
4
Melanoma
4
Laryngeal Neoplasms
4
Hypopharyngeal Neoplasms
4
Locally Advanced Rectal Cancer
3
Liver Neoplasms
3
Turcot syndrome
2
Pathologic Complete Response
2
Pancreatic Neoplasms
2
Ovarian Neoplasms
2
Oropharyngeal Neoplasms
2
Nasopharyngeal Neoplasms
2
Interventions
Nivolumab
5
pembrolizumab
3
avelumab
3
Neoadjuvant Therapy
3
toripalimab
2
durvalumab
2
atezolizumab
2
Celecoxib
2
spartalizumab
1
relatlimab
1
fludarabine phosphate
1
fludarabine
1
dostarlimab
1
danvatirsen
1
XELOX
1
Surgical Procedures, Operative
1
Oxaliplatin
1
Leucovorin
1
Ipilimumab
1
Induction Chemotherapy
1
Immunotherapy
1
Immunoglobulin G
1
Immune Checkpoint Inhibitors
1
IMM-101
1
Fluorouracil
1
Docetaxel
1
Disulfides
1
DEAE-Dextran
1
Cyclophosphamide
1
Chemotherapy, Adjuvant
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 2
×
Turcot syndrome
×
toripalimab
×
Clear all
NCT06903858
2026-05-22
PICC-3
Sun Yat-sen University
Phase 2
Recruiting
105 enrolled
NCT03926338
2025-11-20
PICC
Sun Yat-sen University
Phase 2
Recruiting
270 enrolled